Opinion: The World’s Next Big Health Emergency Is Already Here | Bloomberg

CEID Faculty Dr. Kevin Outterson offered insights about Antimicrobial resistance (AMR):

“…Given the poor market incentives, a problem on this scale requires a coordinated multilateral approach. ‘How many decades of work went into mRNA vaccines; how many scientists around the world, how much money from governments? This wasn’t a miracle; it was built on clever funding,’ says Kevin Outterson, a law professor at Boston University and the executive director of CARB-X, a non-profit that is a major investor in antimicrobials. ‘With vaccine development, the U.S. government took all the commercial questions off the table.’ Antimicrobials deserve similar and with a better funding model, investors will come too, he says…”

Read the full article here